RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 113 filers reported holding RUBIUS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $332,000 | -42.9% | 60,200 | +0.3% | 0.00% | – |
Q4 2021 | $581,000 | -45.9% | 60,000 | 0.0% | 0.00% | – |
Q3 2021 | $1,073,000 | -30.3% | 60,000 | -4.9% | 0.00% | -100.0% |
Q2 2021 | $1,540,000 | -1.8% | 63,100 | +6.6% | 0.00% | 0.0% |
Q1 2021 | $1,569,000 | +165.0% | 59,200 | -24.1% | 0.00% | – |
Q4 2020 | $592,000 | +45.5% | 78,000 | -3.9% | 0.00% | – |
Q3 2020 | $407,000 | -18.3% | 81,200 | -2.5% | 0.00% | – |
Q2 2020 | $498,000 | +61.7% | 83,300 | +20.4% | 0.00% | – |
Q1 2020 | $308,000 | -28.7% | 69,200 | +52.1% | 0.00% | – |
Q4 2019 | $432,000 | -98.0% | 45,500 | -98.4% | 0.00% | -100.0% |
Q3 2019 | $22,094,000 | -44.1% | 2,814,572 | +12.0% | 0.01% | -44.0% |
Q2 2019 | $39,521,000 | -12.7% | 2,512,452 | +0.5% | 0.02% | -13.8% |
Q1 2019 | $45,268,000 | +23.3% | 2,501,014 | +9.5% | 0.03% | +7.4% |
Q4 2018 | $36,727,000 | -5.9% | 2,284,047 | +40.4% | 0.03% | +8.0% |
Q3 2018 | $39,045,000 | – | 1,626,855 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 38,506,526 | $6,546,109 | 0.21% |
HARBOURVEST PARTNERS LLC | 986,878 | $172,704 | 0.06% |
Artal Group S.A. | 2,042,666 | $357 | 0.02% |
Virtu Financial LLC | 68,825 | $12 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 1,277,196 | $222 | 0.00% |
STATE OF MICHIGAN RETIREMENT SYSTEM | 640,000 | $110,144 | 0.00% |
Baillie Gifford | 4,869,126 | $837,977 | 0.00% |
Citadel Advisors | 600 | $103 | 0.00% |
Tower Research Capital LLC (TRC) | 25 | $0 | 0.00% |
JPMORGAN CHASE & CO | 2,196 | $0 | 0.00% |